Literature DB >> 8855800

Catecholamine content and in vitro catecholamine synthesis in peripheral human lymphocytes.

N R Musso1, S Brenci, M Setti, F Indiveri, G Lotti.   

Abstract

We studied the catecholamine (CA) content in peripheral human lymphocytes and the ability of these cells to synthesize CA in vitro. CA were separated by high performance liquid chromatography (HPLC) and determined in the supernatant by electrochemical detection as well as being determined after ultrasonic cell disruption in mononuclear leukocytes, adherent cells (monocytes/macrophages), total lymphocytes, and B- and T-cell enriched fractions. T lymphocytes contained L-Dopa and norepinephrine (NE), whereas B lymphocytes contained only L-Dopa. Lymphocytes seem to be able to synthesize NE from both L-tyrosine and L-Dopa added to the incubation medium in concentrations similar to the peripheral venous plasma (i.e. 5 x 10(-5) m and 10(-8) m, respectively). The addition of D-Dopa did not increase intracellular NE. alpha-methyl-p-L-tyrosine, benserazide, disulfiram, and fusaric acid (which are inhibitors of the enzymatic pathway) all decreased the synthesis of NE. After the addition of [3H]-L-Dopa (10(-8) m and 10(-7) m) to the incubation medium, [3H]-NE and [3H]-dopamine appeared. By increasing the concentration of L-Dopa in the medium (< 10(-6) m), CA were detected in the supernatant as well. These data show that peripheral human T lymphocytes contain and are able to synthesize CA from normal precursors in physiologic concentrations, i.e. a CA synthetic pathway is shown in nonneural cells. These data seem to support the hypothesis of autocrine and paracrine loops in the regulation of lymphocyte activity in lymphocytes taken from human cerebrospinal fluid (as suggested by other authors).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8855800     DOI: 10.1210/jcem.81.10.8855800

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  24 in total

Review 1.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

Review 2.  Dopamine, T cells and multiple sclerosis (MS).

Authors:  Mia Levite; Franca Marino; Marco Cosentino
Journal:  J Neural Transm (Vienna)       Date:  2017-03-10       Impact factor: 3.575

Review 3.  Catecholamines, steroids and immune alterations in ischemic stroke and other acute diseases.

Authors:  Juliane Schulze; Antje Vogelgesang; Alexander Dressel
Journal:  Aging Dis       Date:  2014-10-01       Impact factor: 6.745

Review 4.  Central Noradrenergic Agonists in the Treatment of Ischemic Stroke-an Overview.

Authors:  Zohi Sternberg; B Schaller
Journal:  Transl Stroke Res       Date:  2019-07-20       Impact factor: 6.829

Review 5.  Non-traditional cytokines: How catecholamines and adipokines influence macrophages in immunity, metabolism and the central nervous system.

Authors:  Mark A Barnes; Monica J Carson; Meera G Nair
Journal:  Cytokine       Date:  2015-02-18       Impact factor: 3.861

6.  Innate immunity in insects: surface-associated dopa decarboxylase-dependent pathways regulate phagocytosis, nodulation and melanization in medfly haemocytes.

Authors:  Maria Sideri; Sotiris Tsakas; Eleni Markoutsa; Maria Lampropoulou; Vassilis J Marmaras
Journal:  Immunology       Date:  2007-11-05       Impact factor: 7.397

Review 7.  Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks?

Authors:  Marco Cosentino; Franca Marino
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-17       Impact factor: 4.147

Review 8.  Catecholamines-crafty weapons in the inflammatory arsenal of immune/inflammatory cells or opening pandora's box?

Authors:  Michael A Flierl; Daniel Rittirsch; Markus Huber-Lang; J Vidya Sarma; Peter A Ward
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

Review 9.  Evolution of the Marrow Adipose Tissue Microenvironment.

Authors:  Clarissa S Craft; Erica L Scheller
Journal:  Calcif Tissue Int       Date:  2016-07-01       Impact factor: 4.333

10.  Presence and characterization of the dopamine transporter in human resting lymphocytes.

Authors:  Donatella Marazziti; Stefano Baroni; Mario Catena Dell'Osso; Irene Masala; Laura Fabbrini; Laura Betti; Gino Giannaccini; Bernardo Dell'osso; Antonio Lucacchini
Journal:  Neurochem Res       Date:  2007-11-22       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.